LALPATHLAB.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 06:41):

Stats
Tagesvolumen	57 747.00
Durchschnittsvolumen	271 066
Marktkapitalisierung	199.23B
EPS	INR0 ( 2024-02-01 )
Nächstes Ertragsdatum	( INR6.03 ) 2024-05-08
Last Dividend	INR12.00 ( 2023-08-11 )
Next Dividend	INR0 ( N/A )
P/E	60.63
ATR14	INR3.33 (0.14%)

Volumen Korrelation

Lang: 0.16 (neutral)

Kurz: -0.92 (very strong negative)

Signal:(40.036) Neutral

Dr. Lal PathLabs Limited Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Dr. Lal PathLabs Limited Korrelation - Währung/Rohstoff

0.09
( neutral )

-0.18
( neutral )

-0.21
( neutral )

0.49
( neutral )

-0.15
( neutral )

0.52
( weak )

Dr. Lal PathLabs Limited Finanzdaten

Annual	2022
Umsatz:	INR20.17B
Bruttogewinn:	INR15.70B (77.83 %)
EPS:	INR28.82

FY	2022
Umsatz:	INR20.17B
Bruttogewinn:	INR15.70B (77.83 %)
EPS:	INR28.82

FY	2022
Umsatz:	INR20.87B
Bruttogewinn:	INR13.00B (62.31 %)
EPS:	INR41.70

FY	2021
Umsatz:	INR15.81B
Bruttogewinn:	INR11.84B (74.88 %)
EPS:	INR35.33

Financial Reports:

No articles found.

Dr. Lal PathLabs Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR6.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR12.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Dr. Lal PathLabs Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.87 - low (50.00%) | Divividend Growth Potential Score: 3.08 - Decrease likely (38.31%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.45	2016-07-20
Last Dividend	INR12.00	2023-08-11
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR77.95	--
Avg. Dividend % Per Year	0.37%	--
Score	2.2	--
Div. Sustainability Score	2.87
Div.Growth Potential Score	3.08
Div. Directional Score	2.98	--

Next Divdend (Est)
(2024-06-10)

INR13.50 Estimate 3.71 %

Dividend Stability

0.30 Very Poor

Dividend Score

2.20

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR5.50	0.66%
2019	INR9.50	1.03%
2020	INR12.00	0.78%
2021	INR20.00	0.83%
2022	INR12.00	0.31%
2023	INR12.00	0.55%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SHARDAMOTR.NS	Dividend Junior	2023-09-18	Annually	9	0.90%
MANINDS.NS	Dividend Junior	2023-08-14	Annually	20	1.51%
GRASIM.NS	Dividend Junior	2023-08-11	Annually	23	0.31%
BAJAJFINSV.NS	Dividend Junior	2023-06-29	Annually	17	0.03%
TVSSRICHAK.NS	Dividend Junior	2023-09-04	Annually	18	0.72%
PNCINFRA.NS	Dividend Junior	2023-09-22	Annually	10	0.13%
JMFINANCIL.NS	Dividend Junior	2023-05-19	Annually	18	1.09%
DIXON.NS	Dividend Knight	2023-09-22	Annually	7	0.04%
63MOONS.NS	Dividend Junior	2023-09-20	Annually	20	0.75%
SONATSOFTW.NS	Dividend Knight	2023-07-21	Semi-Annually	23	1.92%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.152	1.500	6.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.190	1.500	9.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	15.29	1.000	5.45	5.45	[3 - 30]
operatingCashFlowPerShareTTM	28.46	2.00	0.514	1.028	[0 - 30]
freeCashFlowPerShareTTM	28.46	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.684	1.000	1.929	1.929	[0.2 - 0.8]
operatingProfitMarginTTM	0.224	1.000	7.52	7.52	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.87

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	60.24	1.000	4.02	0	[1 - 100]
returnOnEquityTTM	0.190	2.50	9.36	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	28.46	2.00	0.514	10.00	[0 - 30]
dividendYielPercentageTTM	1.005	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	28.46	2.00	0.514	1.028	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.109	1.000	9.77	0	[0.1 - 0.5]
Total Score				3.08

Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.